Keeping it Real: Patient Engagement in Evidence Generation

/in , , , , , , , , , /by

Objectives:

Regulatory bodies such as the Food and Drug Administration (FDA) and European Medicines Agency (EMA) are increasingly recognising the value of supplementing clinical trial data with real-world evidence to improve understanding of drug performance in the healthcare setting.

Consequently, Pharma companies are increasingly including real-world studies in their evidence to:

• Understand the opportunities and best practices for involving patient partners in the generation of real-world evidence

• Explore, using case studies, the value of patient engagement in the design, delivery, analysis and communication of real-world studies

• Highlight the importance of Medical Affairs and Health Economics and Outcomes Research (HEOR) professionals in partnering with colleagues from different functions in Pharma to ensure patients are effectively engaged throughout the product lifecycle

• Discuss barriers and propose solutions to optimal patient engagement in real-world studies

Access Options

Putting the AI into Innovative Medical Affairs Teams

/in , , , , , , , , , , , /by

Objectives:

This webinar, hosted by the MAPS APAC Chapter, aims to provide a comprehensive and practical overview of how Artificial Intelligence (AI) can be integrated into various functions of Medical Affairs. Attendees will gain insights into the application of AI in medical strategy, note-taking during advisory boards, setting agendas, and enhancing scientific communication. By the end of the session, participants will have a clear understanding of the tools and techniques available, and how to implement them effectively to improve efficiency and outcomes in their roles.

Objectives:

  • Understand AI Fundamentals: Gain a basic understanding of AI and its relevance to Medical Affairs.
  • Medical Strategy Enhancement: Learn how AI can assist in developing and executing medical strategies.
  • Efficient Note-Taking and Agenda Setting: Explore AI tools for accurate note-taking and effective agenda setting during advisory boards.
  • Scientific Communication: Understand how AI can streamline and improve scientific communications.
  • Practical Implementation: Receive practical tips and best practices for integrating AI into daily Medical Affairs operations.

Access Options

Measuring the Impact of Medical Affairs: A data-driven modular approach

/in , , , , , , , , , , , /by

Objectives:

In this webinar, we will share new data showing that while medical affairs is increasing in importance, it is still struggling to reach a consensus around medical impact metrics. However, measuring medical impact is no longer a choice; it’s a necessity for medical to communicate its value as a business function and better demonstrate its contributions to successful patient outcomes.

Access Options

2024 Benchmark Report: Digital, Advanced Analytics & Artificial Intelligence in Medical Affairs

/in , , , , , , , , , , , , , , , /by

The Medical Affairs Professional Society (MAPS) is pleased to share our 2024 Digital, Advanced Analytics and Artificial Intelligence (AI) in Medical Affairs report. This report is based on findings from 32 leading organizations representing the Pharmaceutical, Biotech, and Medical and Diagnostic Device sectors, and reflects broad leadership thinking about the current and future states of Medical Affairs (MA) AI capability and challenges.

Survey design and analysis: Boston Consulting Group led the preparation, execution and analyses of the GenAI survey and moderated the Ambassador GenAI and Advanced Analytics workshop during the MAPS conference on March 24th, 2024.

Survey respondents: 34 representatives from 32 companies responded to our survey.

Participating companies: Thank you to participants from 3M, Abbott, AbbVie, Amgen, Astellas, AstraZeneca, Baxter, Bayer, bioMérieux, BioNTech, BMS, Eisai, Lilly, Gilead, Ipsen, Jazz Pharmaceuticals, Kyowa Kirin, Lundbeck, Mallinckrodt, Merck & Co, Mundipharma, Novartis, Otsuka, Regeneron, Sanofi, Sumitomo Pharma, Takeda, Teva, UCB, Varian, Vertex, and Viatris for your valuable feedback and insights.

The opinions expressed here are those of members of the MAPS Ambassador Alliance and do not necessarily represent the perspectives of their respective companies.

 

Access Options

Leveraging diverse data sources for more impactful insights analysis

/in , , , , , , , , , , , /by

Objectives:

Determining the most effective medical or commercial strategy requires measuring what’s happening in the market via a strong insights management process. Powering your insights process with different data sources (such as social media and other online conversations, medical information, congresses, advisory boards, and field observations) is critical for a full 360-degree view of the market.

In this discussion, you’ll learn:

  1. Strengths and weaknesses of different insight data sources from a business perspective
  2. How technologies like AI-supported analysis and reporting help you integrate data sources to deeply understand disease communities
  3. Real-world results pharma leaders are achieving by integrating data sources and applying AI-supported insights management processes

Access Options

Three “Generations” of Insights Implementation

/in , , , , , , , , , , , , , , , /by

From the Spreadsheet Age to the Age of Generative AI: Where is your organization on the continuum of Insights Management? (And why no one “age” fits the needs of all teams.)

Read more

Applying Data Visualization, Storytelling, and Interactivity in Medical Affairs: What Journalism Can Teach Us

/in , , , , , , , , , , /by

Objectives:

The objective is to illustrate how the strategic incorporation of interactive tools, visualization, and personalization of content can elevate the communication of medical and scientific information making it more accessible, engaging, and meaningful for diverse audiences. By embracing the innovative techniques from journalism, Medical Affairs professionals can build stronger communications with their audience, allowing for audiences to determine what they choose to view, in what order, and to the level of complexity they prefer. The presentation aims to be a facilitator for innovation, inspiring Medical Affairs professionals to adopt and adapt journalistic interactivity and visualization to their communication strategies.

Access Options

Driving Excellence: Measuring and Enhancing the Performance and Impact of Medical Affairs

Driving Excellence: Measuring and Enhancing the Performance and Impact of Medical Affairs

/in , , , , , , , , , , , , /by

Driving Excellence: Measuring and Enhancing the Performance and Impact of Medical Affairs

Objectives:

This session will delve into maximizing Medical Affairs’ performance and strategic impact through effective metrics and innovative approaches. Learn from industry experts about the strategic goals of Medical Affairs and its unique impact generation in a cross-functional environment. Discover essential metrics for assessing performance and best practices for implementation. Explore cutting-edge data generation methods and technological advancements to enhance data quality and impact measurement.

Key topics to be addressed include:

  1. What is the strategic goal of Medical Affairs and how does it generate impact?

  2. What are the key metrics to measure Medical Affairs’ performance and impact?

  3. How can innovative data approaches enhance measuring Medical Affairs’ impact?

Access Options

Thinking Patient When Thinking Data Dissemination

Thinking Patient When Thinking Data Dissemination

/in , , , , , , , , , , , /by

Thinking Patient When Thinking Data Dissemination

Objectives:

By the end of this webinar, attendees should...

1. Be able to articulate why it’s important to consider a patient community audience when planning scientific and data dissemination including incorporating their voice within it.

2. Be confident to follow clear methodologies to incorporate the patient voice within publications and the role of Medical Affairs in disease awareness campaigns.

3. Be able to implement best practice approaches including novel ways to disseminate information.

Access Options

Omnichannel Integration in Medical Affairs: From Aspiration to Reality

Omnichannel Integration in Medical Affairs: From Aspiration to Reality

/in , , , , , , , , , , , , /by

Omnichannel Integration in Medical Affairs: From Aspiration to Reality

Objectives:

Omnichannel communication holds the promise of reshaping interactions between the pharmaceutical industry and healthcare professionals (HCPs), revolutionizing engagement through personalized and seamless connections. Medical Affairs teams are in a unique position to engage with and provide HCPs with the information and education they seek, including in-depth clinical data, additional analyses and treatment updates. While Medical Affairs teams have the capacity to harness this transformative power, the pharmaceutical industry has been slow to fully embrace this revolution. Crafting effective omnichannel strategies remains a formidable challenge, laden with barriers.

Our webinar offers a platform for attendees to engage with a diverse group of Medical Affairs omnichannel experts, discover their distinctive perspectives, navigate common obstacles, and gain firsthand insights into pragmatic omnichannel integration solutions.

Key areas of focus will include:

·      Unpacking Omnichannel Strategies: Understanding the added value for customers and organizations, and the need to diverge from conventional single or multichannel approaches

·      Overcoming Barriers: Identifying and surmounting the obstacles hindering Medical Affairs teams' success with omnichannel, and exploring actionable solutions

·      Forging the Path to Omnichannel Success: Strategic drivers and actions, and how to institute them effectively across organizational landscapes.

Access Options

Connect with Us

602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073

© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.

Subscribe to MAPS event and resource updates
MAPS Program Support Services
Policies and Positions